Chargement en cours...
AB028. Current status of pharmacotherapy for erectile dysfunction
The advent of phosphodiesterase type 5 (PDE5) inhibition as oral therapy has significantly revolutionized both clinical and basic research in the area of erectile dysfunction (ED). Much of this progress is due to a better understanding in the last three decades of the various pathophysiological and...
Enregistré dans:
| Publié dans: | Transl Androl Urol |
|---|---|
| Auteur principal: | |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
AME Publishing Company
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4842658/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tau.2016.s028 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|